-
D. Boral Capital Reiterates Buy Rating for Trevi Therapeutics (NASDAQ:TRVI)
Источник: Buzz FX / 08 янв 2025 08:56:15 America/New_York
D. Boral Capital Reiterates Buy Rating for Trevi Therapeutics (NASDAQ:TRVI) Written by MarketBeat January 8, 2025 Share Link copied to clipboard. Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) 's stock had its "buy" rating reaffirmed
Read more...